SE9904132D0 - Pharmaceutical composition for treatment of diarrhea - Google Patents
Pharmaceutical composition for treatment of diarrheaInfo
- Publication number
- SE9904132D0 SE9904132D0 SE9904132A SE9904132A SE9904132D0 SE 9904132 D0 SE9904132 D0 SE 9904132D0 SE 9904132 A SE9904132 A SE 9904132A SE 9904132 A SE9904132 A SE 9904132A SE 9904132 D0 SE9904132 D0 SE 9904132D0
- Authority
- SE
- Sweden
- Prior art keywords
- cysteine
- diarrhea
- pharmaceutical composition
- treatment
- prophylactic
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A pharmaceutical composition comprising a colon-specific delivery system and cysteine, cysteine derivatives and/or cysteine-containing compounds, is described. Examples of the active ingredients are cysteine, acetylcysteine, cystine and glutathione. The cysteine, cysteine derivatives and cysteine-containing compounds may be used in a medicament for therapeutic, prophylactic and relapse prophylactic treatment of <i>Clostridium difficile</i> associated diarrhea/disease. A method of therapeutic, prophylactic and relapse prophylactic treatment of <i>Clostridium difficile</i> associa ted diarrhea/disease is also disclosed.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904132A SE9904132D0 (en) | 1999-11-16 | 1999-11-16 | Pharmaceutical composition for treatment of diarrhea |
PCT/SE2000/002241 WO2001035983A1 (en) | 1999-11-16 | 2000-11-15 | Pharmaceutical composition for treatment of diarrhea |
AU17480/01A AU1748001A (en) | 1999-11-16 | 2000-11-15 | Pharmaceutical composition for treatment of diarrhea |
EP00980184A EP1229926A1 (en) | 1999-11-16 | 2000-11-15 | Pharmaceutical composition for treatment of diarrhea |
CA002402811A CA2402811A1 (en) | 1999-11-16 | 2000-11-15 | Pharmaceutical composition for treatment of diarrhea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904132A SE9904132D0 (en) | 1999-11-16 | 1999-11-16 | Pharmaceutical composition for treatment of diarrhea |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9904132D0 true SE9904132D0 (en) | 1999-11-16 |
Family
ID=20417728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9904132A SE9904132D0 (en) | 1999-11-16 | 1999-11-16 | Pharmaceutical composition for treatment of diarrhea |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1229926A1 (en) |
AU (1) | AU1748001A (en) |
CA (1) | CA2402811A1 (en) |
SE (1) | SE9904132D0 (en) |
WO (1) | WO2001035983A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008139947A1 (en) * | 2007-05-08 | 2008-11-20 | Ajinomoto Co., Inc. | Prophylactic or therapeutic agent for diarrhea |
GB2527802B (en) * | 2014-07-02 | 2019-10-16 | Olimed Ltd | An orally disintegrating tablet with differentiated absorption |
US20220096510A1 (en) | 2018-08-17 | 2022-03-31 | Universidad Andrés Bello | Method and pharmacological composition for the prevention of recurrent infections caused by clostridium difficile |
WO2023079335A1 (en) | 2021-11-03 | 2023-05-11 | Universidad Andrés Bello | Composition based on nystatin and vancomycin nanoparticles for the treatment of clostridioides difficile infection and prevention of recurrence |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4587265A (en) * | 1983-02-07 | 1986-05-06 | St. Louis University | Inhibition of diarrhea induced by Escherichia coli heat-stable enterotoxin |
AU4701593A (en) * | 1993-07-22 | 1995-02-20 | Esseti S.A.S. Laboratorio Chimico Farmaco Biologico Di A. Ievoli & C. | Oral pharmaceutical compositions comprising reduced glutathion |
JP2001524087A (en) * | 1997-04-18 | 2001-11-27 | クリンゲ ファーマ ジーエムビーエイチ | Stabilized drugs containing cysteinyl derivatives |
-
1999
- 1999-11-16 SE SE9904132A patent/SE9904132D0/en unknown
-
2000
- 2000-11-15 CA CA002402811A patent/CA2402811A1/en not_active Abandoned
- 2000-11-15 AU AU17480/01A patent/AU1748001A/en not_active Abandoned
- 2000-11-15 WO PCT/SE2000/002241 patent/WO2001035983A1/en not_active Application Discontinuation
- 2000-11-15 EP EP00980184A patent/EP1229926A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2402811A1 (en) | 2001-05-25 |
AU1748001A (en) | 2001-05-30 |
WO2001035983A1 (en) | 2001-05-25 |
EP1229926A1 (en) | 2002-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971889D0 (en) | Compounds and compositions for delivery of active agents | |
BR9912694A (en) | Compound to prepare pulmonary administration medication | |
NO965012D0 (en) | A pharmaceutical composition comprising glucagon | |
AU2001288460A1 (en) | Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant | |
IT1312377B1 (en) | COMPOSITIONS BASED ON TIOTIC ACID, CISTEIN AND / OR N-ACETYL CISTEINADA USE IN PHARMACEUTICAL, DIETETIC AND COSMETIC PREPARATIONS | |
GEP20053602B (en) | Aripiprazole for Oral Administration | |
PT1311285E (en) | Liquid pharmaceutical composition containing a derivative of erythropoietin | |
AU7207098A (en) | Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations | |
AU2001296865A1 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
AR037490A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES | |
ATE311227T1 (en) | FAST-ACTING, FREEZE-DRIED, ORAL, PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF MIGRAINE | |
DE60019334D1 (en) | ANTIVIRAL ARZNEI | |
WO2003028757A1 (en) | Novel method of inducing antigen-specific t cells | |
WO2003028758A1 (en) | Novel method of inducing antigen-specific t cells | |
DK1280558T3 (en) | Semi-solid administration vehicle and pharmaceutical compositions | |
MXPA04003526A (en) | Composition and method for treating diabetes. | |
SE9904132D0 (en) | Pharmaceutical composition for treatment of diarrhea | |
ATE395064T1 (en) | COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONY ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONY ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE INGREDIENTS | |
MXPA02011533A (en) | NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE. | |
DE50114335D1 (en) | LH-RH ANTAGONISTS, THEIR PREPARATION AND THEIR USE AS DRUGS | |
NO20000424D0 (en) | Streptogramins, their preparation and preparations containing the compounds | |
SE9902742D0 (en) | New pharmaceutical formultion | |
SE9800905L (en) | New therapy with glomerulonephritis | |
DE60112578D1 (en) | PHARMACEUTICAL DICLOFENAC COMPOUND BASED ON VITAMIN E, PAPAIN AND HYALURONIDASE | |
DE69902925T2 (en) | New injectable medicinal preparations containing RAMOPLAN |